Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term OutcomeFederico Lussana, Alessandro Rambaldi, Erika Borlenghi et al.|Transplantation and Cellular Therapy|2016Cited by 88
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07Renato Bassan, Alessandro Rambaldi, Chiara Pavoni et al.|Blood Cancer Journal|2020Cited by 45
Up-front blinatumomab improves MRD clearance and outcome in adult Ph– B-lineage ALL: the GIMEMA LAL2317 phase 2 studyRenato Bassan, Robin Foà, Sabina Chiaretti et al.|Blood|2025Cited by 37
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)Renato Bassan, Alessandro Rambaldi, Arianna Masciulli et al.|Blood|2016Cited by 22
Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte®) In Adult Acute Lymphoblastic Leukemia (ALL)Renato Bassan, Alessandro Rambaldi, Arianna Masciulli et al.|Blood|2013Cited by 2